Contact Us
Thank you for considering participation in the PALomino study! You may contact us via the methods listed below. By contacting us to see if you qualify, you will be taking the next step toward helping patients and their doctors be better informed when considering Palynziq® for PKU treatment during pregnancy.
Your participating PALomino study contact is:
Registry Coordinating Center
PalynziqPregnancyStudy@syneoshealth.com
833-672-2203
HEALTHCARE PROFESSIONALS: Please contact the study representative listed above for more information about the study.